US 12,268,717 B1
Enhanced microbial therapeutic agents
Malireddy S. Reddy, Cherry Hills Village, CO (US)
Filed by Malireddy S. Reddy, Cherry Hills Village, CO (US)
Filed on Mar. 1, 2024, as Appl. No. 18/593,739.
Int. Cl. A61K 35/744 (2015.01); A61K 35/00 (2006.01); A61K 35/741 (2015.01); A61K 35/742 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); A61K 36/064 (2006.01); A61K 36/235 (2006.01); A61K 36/48 (2006.01); A61K 39/00 (2006.01); C12N 1/20 (2006.01)
CPC A61K 35/744 (2013.01) [A61K 35/741 (2013.01); A61K 35/742 (2013.01); A61K 35/745 (2013.01); A61K 35/747 (2013.01); A61K 36/064 (2013.01); A61K 36/235 (2013.01); A61K 36/48 (2013.01); C12N 1/20 (2013.01); A61K 2035/115 (2013.01); A61K 2039/521 (2013.01)] 6 Claims
 
1. A dosage unit of a therapeutic composition for improving stamina in a human or an animal subject in need thereof, wherein the dosage unit comprises:
a first preparation of a non-enhanced therapeutic agent, wherein the non-enhanced therapeutic agent comprises an effective dosage of turmeric; and
a second preparation comprising a mixture of paraprobiotics of inactivated probiotics of Streptococcus thermophilus, Lactobacillus acidophilus, Bacillus coagulans, and Propionibacterium shermanii and postbiotic growth end products or immunomodulins of said probiotics, wherein the mixture is present in a quantity sufficient to enhance the stamina-improving effect of the dosage unit,
wherein the dosage unit does not comprise live probiotics and wherein the mixture in the second preparation enhances the stamina-improving effect of the dosage unit.